Piercan

Piercan

Private
FranceHealthcare & Life Scienceshttps://piercan.com/

Last Round

Buyout/LBO

Mar 21, 2023

Est. Valuation

$183.6M

Momentum Score

50 /100

Company Overview

Piercan is a commercial products company that manufactures containment gloves and technical parts for the pharmaceutical, nuclear, and other industries.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Advanced Materials, Pharma Supply Chain, Space Technology

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

containment glovesglove box glovesisolator glovescontainment technologyflexible isolatorscontamination controlaseptic processingelastomer manufacturingcleanroom suppliesbarrier technologynuclear containmentpharma manufacturing equipmentsecure glove change systemsRABS componentstechnical elastomer parts

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Piercan Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Piercan Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Buyout/LBOMar 21, 2023

Piercan Investors

Notable investors and investment history

InvestorRounds
Normandie ParticipationsBuyout/LBO
Siparex GroupBuyout/LBO
Mérieux Equity PartnersBuyout/LBO

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 5, 2026

    Monthly visitors increased 61% MoM.

  • Jul 2, 2025

    Monthly visitors grew 48% MoM, reaching 1.2K.

Piercan Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Piercan Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Piercan's valuation, stock price, and market status.

Firmographic Details

HeadquartersFrance
Employee Range14
Year Founded1948
Last FundingMar 21, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.